688278

Xiamen Amoytop Biotech
688278

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
CN„29.48B
EV
CN„28.68B
Shares Outstanding
406.80M
Beta
-0.32

Wall Street View

Analyst Rating
BUY
Analyst Target Price
CN„84.34
P/E 2025E
27.48x
P/Revenue 2025E
7.90x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Xiamen Amoytop Biotech Co., Ltd.

gainify
688278

Xiamen Amoytop Biotech Co., Ltd.

688278

Xiamen Amoytop Biotech Co., Ltd. engages in the manufacture, marketing, and sale of recombinant protein drugs in China. It provides solutions for diseases, such as viral hepatitis, malignant tumors, and immunotherapy. The company was founded in 1996 and is based in Xi...

Sector

Healthcare

Industry

Biotechnology

CEO

Sun, Li

Employees

2,423

IPO Date

2020-01-17

Headquarters

No. 330 Wengjiao Road, Xinyang Industry Zone of Haicang, Xiamen, Fujian Province, 361022, China

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.